Clinical Trial Update: Rivaroxaban Post Coronary Bypass Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating rivaroxaban after coronary bypass surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cardiovascular Disease After Coronary Bypass Surgery

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Post Coronary Bypass Surgery Patients | Phase 4 | Status: COMPLETED